These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15898030)

  • 1. Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
    Kindler CH; Yost CS
    Reg Anesth Pain Med; 2005; 30(3):260-74. PubMed ID: 15898030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5).
    Kindler CH; Paul M; Zou H; Liu C; Winegar BD; Gray AT; Yost CS
    J Pharmacol Exp Ther; 2003 Jul; 306(1):84-92. PubMed ID: 12660311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiology and pharmacology of two-pore domain potassium channels.
    Kim D
    Curr Pharm Des; 2005; 11(21):2717-36. PubMed ID: 16101451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on tandem pore (2P) domain K+ channels.
    Yost CS
    Curr Drug Targets; 2003 May; 4(4):347-51. PubMed ID: 12699355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem.
    Kindler CH; Yost CS; Gray AT
    Anesthesiology; 1999 Apr; 90(4):1092-102. PubMed ID: 10201682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics.
    Liu C; Au JD; Zou HL; Cotten JF; Yost CS
    Anesth Analg; 2004 Dec; 99(6):1715-1722. PubMed ID: 15562060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuronal background K2P channels: focus on TREK1.
    Honoré E
    Nat Rev Neurosci; 2007 Apr; 8(4):251-61. PubMed ID: 17375039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pharmacology of Two-Pore Domain Potassium Channels.
    Kamuene JM; Xu Y; Plant LD
    Handb Exp Pharmacol; 2021; 267():417-443. PubMed ID: 33880623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.
    Gierten J; Ficker E; Bloehs R; Schlömer K; Kathöfer S; Scholz E; Zitron E; Kiesecker C; Bauer A; Becker R; Katus HA; Karle CA; Thomas D
    Br J Pharmacol; 2008 Aug; 154(8):1680-90. PubMed ID: 18516069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vernakalant activates human cardiac K(2P)17.1 background K(+) channels.
    Seyler C; Schweizer PA; Zitron E; Katus HA; Thomas D
    Biochem Biophys Res Commun; 2014 Aug; 451(3):415-20. PubMed ID: 25108155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.
    Bayliss DA; Barrett PQ
    Trends Pharmacol Sci; 2008 Nov; 29(11):566-75. PubMed ID: 18823665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channels.
    Gierten J; Hassel D; Schweizer PA; Becker R; Katus HA; Thomas D
    Biochim Biophys Acta; 2012 Jan; 1818(1):33-41. PubMed ID: 21963410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of two-pore domain potassium channels in rat cerebellar granule neurons.
    Burgos P; Zúñiga R; Domínguez P; Delgado-López F; Plant LD; Zúñiga L
    Biochem Biophys Res Commun; 2014 Oct; 453(4):754-60. PubMed ID: 25305496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of two-pore-domain potassium (K(2P)) channels in the cardiovascular system.
    Wiedmann F; Schmidt C; Lugenbiel P; Staudacher I; Rahm AK; Seyler C; Schweizer PA; Katus HA; Thomas D
    Clin Sci (Lond); 2016 May; 130(9):643-50. PubMed ID: 26993052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological roles of heteromerization: focus on the two-pore domain potassium channels.
    Khoubza L; Chatelain FC; Feliciangeli S; Lesage F; Bichet D
    J Physiol; 2021 Feb; 599(4):1041-1055. PubMed ID: 33347640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of covalent chemogenetic K
    Deal PE; Lee H; Mondal A; Lolicato M; Mendonça PRF; Black H; Jang S; El-Hilali X; Bryant C; Isacoff EY; Renslo AR; Minor DL
    Cell Chem Biol; 2024 Jul; 31(7):1305-1323.e9. PubMed ID: 39029456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem pore domain K channels: an important site of volatile anesthetic action?
    Yost CS
    Curr Drug Targets; 2000 Sep; 1(2):207-17. PubMed ID: 11465071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of leak potassium channels in pain signaling.
    Li XY; Toyoda H
    Brain Res Bull; 2015 Oct; 119(Pt A):73-9. PubMed ID: 26321392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of two-pore-domain potassium channels in the adult rat vestibular periphery.
    Popper P; Winkler J; Erbe CB; Lerch-Gaggl A; Siebeneich W; Wackym PA
    Hear Res; 2008 Dec; 246(1-2):1-8. PubMed ID: 18838117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.